Amphastar Pharmaceuticals, Inc. (AMPH) › Gross ProfitAmphastar Pharmaceuticals, Inc. (AMPH) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2012: $90.30M2013: $86.96M2014: $51.26M2015: $77.35M2016: $104.20M2017: $90.51M2018: $106.98M2019: $131.92M2020: $143.34M2021: $199.74M2022: $248.86M2023: $351.12M2024: $373.86M2025: $356.06M$356.06M2012Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$356.06M-4.8%2024$373.86M+6.5%2023$351.12M+41.1%2022$248.86M+24.6%2021$199.74M+39.3%2020$143.34M+8.7%2019$131.92M+23.3%2018$106.98M+18.2%2017$90.51M-13.1%2016$104.20M+34.7%2015$77.35M+50.9%2014$51.26M-41.1%2013$86.96M-3.7%2012$90.30M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share